Lilly partners with UnitedHealth to conduct 'real-world' study for its Covid-19 antibody bamlanivimab
As Eli Lilly continues to build out data for their FDA-authorized Covid-19 treatment bamlanivimab, they’ve been seeking new partners to conduct more trials. And the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.